Could a sleep supplement help reduce chronic pain?
From Health Report · · 44 min
This plays from the publisher's own server. We do not host a copy.
Description
While looking for ways to treat pain in those with musculoskeletal disorders, researchers examined studies in which sleep supplement melatonin had been used.
A study into the behaviour of immune cells in coeliac disease patients showed surprising results. Instead of being overactive, T cells in coeliac disease were subdued, and didn't survive as long as T cells from healthy people.
Spinal stimulators have been in use for many years, but the evidence for their benefit, or otherwise has been unclear until now.
References
- Efficacy and effectiveness of melatonin for the management of musculoskeletal pain: a systematic review and meta-analysis of placebo and active controlled trials (https://journals.lww.com/pain/fulltext/9900/efficacy_and_effectiveness_of_melatonin_for_the.1225.aspx)
- Functional immune profiling reveals CD4+ T cell dysregulation in coeliac disease (Immunology and Cell Biology, 2026) (https://onlinelibrary.wiley.com/doi/10.1111/imcb.70132)
- Transcutaneous spinal cord stimulation plus locomotor training versus sham-stimulation plus locomotor training in chronic spinal cord injury (eWALK): a multicentre, triple-blind, randomised, sham-controlled trial (https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00049-0/fulltext)
- The little-known cause of heart attack in young women (https://www.abc.net.au/listen/programs/healthreport/scad-heart-attack-young-women/104143436)
- Worsening Asthma Outcomes in Australian Adults: A Comparison of Stratified Sample Surveys in 2012 and 2021 (https://onlinelibrary.wiley.com/doi/10.5694/mja2.70221)
- Most Australians unaware of 'black triangle' medicine side effects reporting scheme: study (https://www.abc.net.au/news/health/2026-06-30/black-triangle-scheme-tga-awareness-public/106798208)
- New pneumococcal vaccine for adults on the NIP (https://www.health.gov.au/ministers/the-hon-mark-butler-mp/media/new-pneumococcal-vaccine-for-adults-on-the-nip?language=en)
- Statement from Invidior on removal of Sublocade from Australian market (https://live-production.wcms.abc-cdn.net.au/e0143400e8fe9f9ad6542b4af00a4c2a)